Liver failure in a patient receiving rosiglitazone therapy [3]

Diabetic Medicine

Volumn 23, Issue 1, 2006, Pages 105-106

  Su, D H ^a   Lai, M Y ^a   Wu, H P ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; METFORMIN; ROSIGLITAZONE; TROGLITAZONE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADD ON THERAPY; ADULT; ANAMNESIS; ANOREXIA; BLOOD CLOTTING TEST; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE EXACERBATION; EPIGASTRIC PAIN; FEMALE; HEPATITIS B; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LABORATORY TEST; LETTER; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; NAUSEA; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL;

DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIVER FAILURE; LIVER FUNCTION TESTS; MIDDLE AGED; THIAZOLIDINEDIONES;

EID: 33645064541     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01791.x     Document Type: Letter

References (7)

1. Lebovitz HE Salzman A Rosiglitazone liver safety update Diabetes 2000 49 A39
2. Forman LM Simmons DA Diamond RH Hepatic failure in patient taking rosiglitazone Ann Intern Med 2000 132 118 121
3. Gouda HE Khan A Schwartz J Cohen RI Liver failure in a patient treated with long-term rosiglitazone therapy Am J Med 2001 111 584 585
4. Scheen AJ Hepatototoxicity with thiazolidinediones: is it a class effect? Drug Safety 2001 24 873 888
5. Naranjo CA Busto U Sellers EM Sandor P Ruiz I Roberts EA et al. A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 1981 30 239 245
6. Schiodt FV Balko J Schilsky M Harrison ME Thornton A Lee WM Thrombopoietin in acute liver failure Hepatology 2003 37 558 561
7. Gitlin N Julie NL Spurr CL Lim KN Juarbe HM Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone Ann Intern Med 1998 129 36 38